This site uses cookies to provide services, collect traffic data, and personalize ads. You agree by using this site.
More info
Press releases

NEXTCLINICS adds the IVF Centers of Prof. Zech to portfolio and becomes one of the Europe’s 3 largest assisted reproductive technology providers


Bregenz/Salzburg/Augsburg, 1 August 2018: On the heels of acquiring Italy’s GynePro Medical Group in June 2018, NEXTCLINICS is proud to announce it will take control of 100% of The IVF Centers Prof. ZECH (Zech IVF), one of Europe’s largest networks of in-vitro fertilization (IVF) clinics with offices in Bregenz, Salzburg, Cologne, Vaduz, Niederuzwil, Pilsen and Merano. In less than a year, NEXTCLINICS has expanded to be among Europe’s top 3 IVF providers with 14 clinics in its portfolio across the continent. NEXTCLINICS now has the perfect platform to invest into further European and global growth. Because of the enormous overlap of philosophy and principles between the two groups, Zech IVF’s founder Professor Dr. Herbert Zech has become shareholder in NEXTCLINICS. Further, Professor Zech will join the Medical Board in a leading position and will support the further international expansion of NEXTCLINICS. The transaction is part of the NEXTCLINICS plan to invest up to EUR 200 million in 2018. The valuation of the Zech IVF transaction will not be disclosed and is subject to Austrian anti-trust regulatory approval.

“This is a game changer. Having this brand in our group is critical for further European and global growth. Professor Zech’s quality standards, research, reputation, and success rates are outstanding and it is an honor to call him and his team our partner. With this transaction, we are doubling in size and outperforming our expansion plans. With every passing day, we are getting closer to being the biggest, most significant force in the European IVF sector,” explains Miroslaw Herden, CEO of NEXTCLINICS.

“We opened the clinic 34 years ago. Our goal was to treat patients on an individual basis by applying the latest and safest technologies in order for them to conceive a healthy child, whenever possible at the first attempt. That hasn’t changed. What has changed, however, is our ability to independently grow and at the same time continue to foster the unique doctor-patient relationship that is crucial to success. By investing and partnering with NEXTCLINICS, our entire team can focus on what we do best while NEXTCLINICS adds strategic geographic coverage with clinics that offer a convergence of research, modern technology, and alternative treatments,” said Professor Dr. Herbert Zech.

NEXTCLINICS’ expanded network, with close proximity to major commercial centers coupled with successful clinics in the strategically critical Alpine region, significantly increases its ability to receive incoming patients from Europe and abroad, while also serving as a powerful blueprint for further expansion.

“The level of mutual understanding in terms of philosophy and approach between NEXTCLINICS and Professor Zech is truly remarkable. He and his family were so convinced of our concept that they decided to combine their life’s work with NEXTCLINICS, which is a great honor. We will immediately be able to benefit from integrating Professor Zech’s developed infrastructure in terms of IT, data, and most importantly customer care; all created in order to best service every single patient,” NEXTCLINICS CFO Markus Stötter explained.

NEXTCLINICS can confirm that there will be no changes to the current operations or management of Zech IVF.

NEXTCLINICS European Portfolio

NEXTCLINICS INTERNATIONAL invested EUR 80 million in 2017 and forecasted investments of up to EUR 200 million in 2018. The IVF Centers of Prof. ZECH joins a growing portfolio that includes GynePro Medical Group, specialists in the area of reproductive disorders, infertility, and prenatal diagnosis from Bologna and Verona; the ProCrea Group in Lugano offering IVF and specialized diagnostic services as well as plastic surgery and genetics; IMER in Valencia and Denia, Spain, a leader in egg and sperm donation in Europe; as well as the Praxisklinik Frauenstraße Clinic in Ulm, Germany; Genetika Pilsen and the GEST Centre of Reproductive Medicine & Gynecology in Prague, the Czech Republic.

NEXTCLINICS has also invested in other facilities including hospitals, medical laboratories, and a network of blood sampling and tissue collection centers in the Czech Republic, Italy, Germany, Spain, and Switzerland.


NEXTCLINICS operates a network of modern and highly-specialized healthcare facilities and offers primarily care in fertility, allergology, clinical immunology, pneumology, as well as other related fields. Entering the European market in 2015, this dynamically growing healthcare company with headquarters in Germany aims to foster innovative procedures in healthcare combining the latest diagnostic and treatment methods with a patient- and client-centric approach while using cutting-edge communication technology. Services are available in the Czech Republic, Italy, Germany, Spain, and Switzerland while also serving other countries. Find more information at

About IVF Centers Prof. ZECH

The IVF Centers Prof. Zech, currently located in five European countries and employ more than 120 medical experts are among Europe’s leading private clinic groups in the field of reproductive medicine. Their commitment to the highest standards in technology, science, and research serve to meet the goal of providing the best possible care for patients. The IVF Centers Prof. Zech enjoy worldwide respect in treating infertility and developing medical options in assisted reproductive technology (ART) in order to provide couples with an optimum level of support to enhance their chances of conceiving and delivering a healthy child.

Back to overview

Other articles

NEXTCLINICS continues growing, the group acquired prominent assisted reproduction clinics in Northern Italy 

Bologna/Augsburg, 17 July 2018: In late June 2018, NEXTCLINICS acquired 100% of GynePro, an Italian medical Group with in-vitro fertilization (IVF) clinics located in Bologna and Verona. With a 20 year history, GynePro is a highly experienced and renowned medical group active in the area of infertility management, assisted reproductive technology (ART), and prenatal diagnosis. GynePro’s founder, Professor Dr. Marco Filicori, will remain with the clinic as its Medical Director and will become a shareholder and investor in NEXTCLINICS. This transaction strengthens NEXTCLINICS’ position as a leading pan European provider of ART clinics and laboratories. This is NEXTCLINICS’ first major transaction in 2018, and follows a number of late 2017 investments in leading fertility centers and laboratories across Europe, valued at 80 million Euro. The valuation of the GynePro transaction will not be disclosed.

NL Holding announces it has secured Oaktree Capital Management as its partner for further expansion and the acquisition

NL Holding announces it has secured Oaktree Capital Management, a major global investment group, as its partner for further expansion and the acquisition of healthcare facilities in Spain, Italy, and Switzerland.

Press releases overview...

NEXTCLINIC operates a network of modern and highly specialized healthcare facilities and offer care primarily in allergology, clinical immunology, pneumology, phtiseology as well as other related fields. We are a leading provider of assisted reproduction services (IVF), gynecology and obstetrics, and offer a diverse range of complimentary services. Our central fundamental guiding principle lies in a responsible and accountable approach to patients, one where information is shared, and where patients are encouraged to take an active role in their own wellbeing.

With presence on multiple European markets, NEXTCLINIC offers patients from around the world the opportunity to choose a preferred location and enjoy the benefits of unique destinations. Customers enjoy healthcare services, but also a wide range of complimentary services.

Project permeating across several disciplines, providing patients the ability to identify and integrate a whole new social group to gain many benefits. It creates opportunities for testing of your health and makes information about health and healthy lifestyle accessible.

The NEXTLIFE application change trends in patient communication with a physician. We allow quality and fast testing, where the patient can determine the time and method of examination. The NEXTLIFE magazine focuses on a healthy lifestyle.

NEXTLAB provides fast and accurate laboratory diagnostics on biological material for private GPs, outpatient specialists, hospitals, patients without a health insurance policy, and those who request laboratory services beyond standard testing.

NEXTLAB builds upon 20 years of experience with its own labs and sample collection centres, offering a wide range of lab tests based on the latest diagnostic methods, devices and technologies. Tests that are not carried out in our labs are forwarded to partner labs in compliance with a strict pre-analytical procedure.

You are leaving NEXTCLINICS website.

For more information about selected services, you will be redirected to %s.
Do you want to continue?